Author

E.-M. Zangerl-Plessl

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Assay:electrophysiology· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

A. Garon· 1 shared A. Stary-Weinzinger· 1 shared M. A. G. van der Heyden· 1 shared M. J. C. Houtman· 1 shared M. Wieder· 1 shared T. Langer· 1 shared X. Chen· 1 shared

Activity by Year

2019-2019 · peak 1/yr

Co-Author Collaboration Network

7 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

A. Garon

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Computational identification of novel Kir6 channel inhibitors

X. Chen, A. Garon, M. Wieder, M. J. C. Houtman, E.-M. Zangerl-Plessl, T. Langer, M. A. G. van der Heyden, A. Stary-Weinzinger

This study identifies novel Kir6 channel inhibitors using computational methods, validated by experimental analysis, with potential for treating Cantu syndrome.

bioRxiv · Feb 3, 2019Pharmacology & Toxicology